Dose tapering to withdrawal stage and long‐term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open‐label extension study
Journal of Thrombosis and Haemostasis2021Vol. 20(3), pp. 716–728
Citations Over TimeTop 21% of 2021 papers
Heng Mei, Xiaofan Liu, Yan Li, Hu Zhou, Ying Feng, Guangxun Gao, Cheng Peng, Ruibin Huang, Linhua Yang, Jianda Hu, Ming Hou, Yazhou Yao, Li Liu, Yi Wang, Depei Wu, Liansheng Zhang, Changcheng Zheng, Xuliang Shen, Qi Hu, Jing Liu, Jie Jin, Jianmin Luo, Yun Zeng, Sujun Gao, Xiaohui Zhang, Xin Zhou, Qingzhi Shi, Ruixiang Xia, Xiaobao Xie, Zhongxing Jiang, Li Gao, Yuansong Bai, Yan Li, Junye Xiong, Runzi Li, Jianjun Zou, Ting Niu, Renchi Yang, Yu Hu
Related Papers
- → A systematic review of adverse events in placebo groups of anti-migraine clinical trials(2009)227 cited
- → Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation(2017)71 cited
- → Efficacy confirmation study of aceneuramic acid administration for GNE myopathy in Japan(2023)16 cited
- → Safety of Placebo Controls in Pediatric Hypertension Trials(2008)18 cited
- → A pilot study of dimethyl fumarate in pulmonary arterial hypertension associated with systemic sclerosis(2021)8 cited